目录产品 » HLA-A*02:01&B2M&MART-1 (ELAGIGILTV) Monomer, His & Avi, Human
Manual
SDS
COAs

HLA-A*02:01&B2M&MART-1 (ELAGIGILTV) Monomer, His & Avi, Human

Melanoma antigen recognized by T cell-1 (Mart-1), one of the melanosome-specific proteins, also recognized by cytotoxicity T lymphocytes as a marker. Mart-1 is considered to play a critical role in the immunotherapy for melanoma.
￥3000
Z06544-100

产品简介
Species Human
Protein Construction
HLA-A*02:01&B2M&MART-1 (ELAGIGILTV) Monomer [Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and ELAGIGILTV peptide]
Accession # A0A140T913(HLA-A*02:01)&P61769(B2M)&ELAGIGILTV		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 50.40 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 53-63 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.
返回

技术背景
Target Background Melanoma antigen recognized by T cell-1 (Mart-1), one of the melanosome-specific proteins, also recognized by cytotoxicity T lymphocytes as a marker. Mart-1 is considered to play a critical role in the immunotherapy for melanoma.
Synonyms MART1; LB39-AA; SK29-AA; Melan-A; MLANA
返回

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.